Assistant Professor, Pediatrics, University of Colorado School of Medicine
Pediatric Hematology & Oncology
Dr. Amy K. Keating, MD
|
|
Give Review
Keating is an expert in the field of Pediatric Hematology & Oncology. She went to Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19/29 in Research/PrimaryCare. Amy K. Keating has written publications. She has 19 publications published with PubMed. The lastest publication is: 'Creating anatomically accurate and reproducible intracranial xenografts of human brain tumors.'
Publications
- Asiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivo.
- MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.
- TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system.
- Mer receptor tyrosine kinase is a therapeutic target in pre-B cell Acute lymphoblastic leukemia.
- Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in Acute myeloid leukemia.
- Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age.
- Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology.
- Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria.
- Targeting paediatric Acute lymphoblastic leukaemia: novel therapies currently in development.
- Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.
- Thymoma in children: report of 2 cases and review of the literature.
- Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.
- Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell Acute lymphoblastic leukemia.
- Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress.
- TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human Cancer.
- Lymphoblastic Leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase.
- Ectopic expression of the proto-oncogene Mer in pediatric T-cell Acute lymphoblastic leukemia.
- Creating anatomically accurate and reproducible intracranial xenografts of human brain tumors.
Schools
Northwestern University The Feinberg School Of Medicine
University Of Colorado Children S Hospital Colorado Program
Conditions Treated
- Acute Leukemia
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Lung Cancer
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
University of Colorado -
Loyola University -
Northwestern University Feinberg School of Medicine
Hospital
-
Children's Hospital Colorado
Helpful Reviews
Similar Doctors
|
Dr. Keren E. Call, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian S. Greffe, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Roger H. Giller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy P. Garrington, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|